Proposal of New Prognostic Index for Patients with Diffuse Large B-Cell Lymphoma in the Rituximab Era

被引：0
|
作者：
Yoon, Shinkyo [1 ]
Yoon, Dok Hyun [1 ]
Kim, Shin [2 ]
Lee, Kyoungmin [2 ]
Kang, Eun Hee [2 ]
Lee, Sang-wook [3 ]
Park, Chan-Jeoung [4 ]
Park, Chan-Sik [5 ]
Huh, Jooryung [5 ]
Suh, Cheolwon [2 ]
机构：
[1] Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiat Oncol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Lab Med, Seoul, South Korea
[5] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Diminishing prognostic role of preexisting diabetes mellitus for patients with diffuse large B-cell lymphoma in the rituximab era
    Lu, Hsueh-Ju
    Huang, Yu-Chung
    Liu, Chun-Yu
    Hung, Man-Hsin
    Hu, Ming-Hung
    Wu, Chia-Yun
    Hong, Ying-Chung
    Hsiao, Liang-Tsai
    Gau, Jyh-Pyng
    Liu, Jin-Hwang
    Hsu, Hui-Chi
    Chiou, Tzeon-Jye
    Tzeng, Cheng-Hwai
    Yu, Yuan-Bin
    ANNALS OF HEMATOLOGY, 2013, 92 (11) : 1495 - 1501
  • [22] Outcomes of Cardiac Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Al-Juhaishi, Taha
    Abu Zeinah, Ghaith
    Al-Kindi, Sadeer
    BLOOD, 2020, 136
  • [23] Primary breast diffuse large B-cell lymphoma in the era of rituximab
    Zhang, Na
    Cao, Caineng
    Zhu, Yuan
    Liu, Peng
    Liu, Luying
    Lu, Ke
    Luo, Jialin
    Zhou, Ning
    ONCOTARGETS AND THERAPY, 2016, 9 : 6093 - 6097
  • [24] Rebirth of radiotherapy for elderly patients with diffuse large B-cell lymphoma in the rituximab era
    Flowers, Christopher R.
    Cohen, Jonathon B.
    Khan, Mohammad K.
    LEUKEMIA & LYMPHOMA, 2015, 56 (03) : 557 - 558
  • [25] THE HIGHEST PROGNOSTIC IMPACT OF LDH AMONG INTERNATIONAL PROGNOSTIC INDICES IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN THE RITUXIMAB ERA
    Park, J. H.
    Suh, C.
    Yoon, D. H.
    Kim, S. M.
    Kim, D. Y.
    Kim, S.
    Kim, J.
    Kim, K. A.
    Lee, S. W.
    Park, C.
    Huh, J.
    HAEMATOLOGICA, 2012, 97 : 128 - 128
  • [26] SIL INDEX AS A NEW PROGNOSTIC PREDICTOR IN DIFFUSE LARGE B-CELL LYMPHOMA
    Tomita, N.
    Sakai, R.
    Fujisawa, S.
    Fujimaki, K.
    Taguchi, J.
    Hashimoto, C.
    Ogawa, K.
    Yamazaki, E.
    Ishigatsubo, Y.
    HAEMATOLOGICA, 2012, 97 : 315 - 315
  • [27] Statin Use and Prognosis in Patients With Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in the Rituximab Era
    Nowakowski, Grzegorz S.
    Maurer, Matthew J.
    Habermann, Thomas M.
    Ansell, Stephen M.
    Macon, William R.
    Ristow, Kay M.
    Allmer, Cristine
    Slager, Susan L.
    Witzig, Thomas E.
    Cerhan, James R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 412 - 417
  • [28] PHARMACOKINETICS OF RITUXIMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Rozman, S.
    Grabnar, I.
    Novakovic, S.
    Mrhar, A.
    Novakovic, B. Jezersek
    HAEMATOLOGICA, 2017, 102 : 688 - 688
  • [29] Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story
    Bari, A.
    Marcheselli, L.
    Sacchi, S.
    Marcheselli, R.
    Pozzi, S.
    Ferri, P.
    Balleari, E.
    Musto, P.
    Neri, S.
    Spiriti, M. A. Aloe
    Cox, M. C.
    ANNALS OF ONCOLOGY, 2010, 21 (07) : 1486 - 1491
  • [30] Serum B-cell activating factor (BAFF) in diffuse large B-cell lymphoma: Its prognostic significance in the rituximab era
    Kim, Seok Jin
    Sung, Hwa Jung
    Choi, Chul Won
    Kim, In Sun
    Kim, Byung Soo
    Yoon, Soo-Young
    Won, Jong-Ho
    Kim, Jun Suk
    BLOOD, 2007, 110 (11) : 470A - 471A
12345